Back to News
Market Impact: 0.3
Amphastar Pharmaceuticals (AMPH) Tops Q3 Earnings and Revenue Estimates
Source: zacks.com
Corporate EarningsHealthcare & BiotechCompany FundamentalsAnalyst Estimates
Amphastar Pharmaceuticals reported quarterly earnings of $1.14 per share, beating the Zacks consensus estimate of $0.78 by $0.36, or about 46%. EPS was up from $0.93 a year earlier.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.35
Ticker Sentiment
AMPH0.60
More News
- Tech stocks are suffering their biggest selloff since Covid, as investors see premature end to AI datacenter boom
- Elon Musk's Tesla and SpaceX lose over $420 billion in combined market cap after midterms
- Qualcomm slides 9% after earnings, leading post-election chip stock sell-off
- Costco is taking aim at its May record high — how it got here and where's it going
- Neocloud IREN says $4 billion in annualized revenue being delayed due to customer request
- Tapestry CEO on Earnings Beat, Consumer Outlook